All patients whose tumors had concurrent mutations in multiple PIK3 pathway genes were in an advanced (IV) stage, which suggests that concerted PI3K pathway aberrations occur with tumor progression in HNSCC [3]. This evidence concerns the gene PIK3CG and neoplasm.